A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents
PHASE4
The main objective is to determine whether immune responses to Tdap (GlaxoS...
Status
Completed
Location
Birmingham Pediatrics, 806 Saint Vincent's Drive, Suite 615